Business context and reporting period
This filing is Ambac Financial Group, Inc.’s Form 10-K for the fiscal year ended December 31, 2015. The source text identifies Ambac Financial Group, Inc., not Octave Specialty Group Inc. Ambac is a financial services holding company that emerged from Chapter 11 in 2013. Its Financial Guarantee and Financial Services segments are substantially in runoff and are focused on portfolio remediation, recoveries, commutations, asset management and selective diversification.
Ambac Assurance Corporation is not itself in rehabilitation, but its Segregated Account remains under Wisconsin rehabilitation proceedings and is controlled by the Rehabilitator. The filing states that these circumstances create substantial doubt about Ambac’s ability to continue as a going concern; the financial statements nevertheless use the going-concern basis.
Key financial metrics
| Metric | 2015 | 2014 | Change or context |
|---|---|---|---|
| Net premiums earned | $312.6 million | $246.4 million | Up 26.9%, primarily from accelerated premium earnings |
| Net investment income | $266.3 million | $300.9 million | Down $34.6 million on a lower asset base |
| Derivative product revenues | $(42.5) million | $(181.1) million | Loss narrowed substantially |
| Loss and loss expenses | $(768.7) million benefit | $(545.6) million benefit | Improved development, recoveries and commutations, partly offset by deferred-amount interest and public finance deterioration |
| Goodwill impairment | $514.5 million | None | Full non-cash, non-tax-deductible impairment |
| Net income attributable to common shareholders | $493.4 million | $484.1 million | Diluted EPS of $10.72 versus $10.31 |
| Total comprehensive income attributable to Ambac | $288.3 million | $692.7 million | Reduced by $205.4 million of other comprehensive loss |
| Operating earnings, non-GAAP | $1.165 billion | $682.6 million | Excludes selected non-economic and non-recurring items |
| Adjusted book value, non-GAAP | $1.116 billion | $337.4 million | $24.78 per share versus $7.50 |
| Total assets | $23.7 billion | $25.2 billion | Down approximately $1.4 billion |
| Total stockholders’ equity | $2.0 billion | $1.7 billion | Increased primarily from net income |
| Cash and cash equivalents | $35.7 million | $73.9 million | Declined $38.2 million |
| Non-VIE investments | $5.645 billion | $5.507 billion | Increased modestly |
| Long-term debt | $1.125 billion | $971.1 million | Increased, including a 2015 secured borrowing |
| Loss and loss expense reserves | $4.088 billion | $4.752 billion | Declined $663.9 million |
Cash flow and liquidity
- Operating cash flow was $87.5 million, compared with $(971.5) million in 2014.
- Investing cash flow was $(172.6) million, while financing cash flow was $46.9 million. Net cash flow was $(38.2) million.
- Ambac reported $147.6 million of liquid cash and investments at the holding-company level, plus $88.5 million of less-liquid investments in Ambac-insured RMBS and Ambac Assurance surplus notes.
- Ambac expected to receive approximately $70.9 million of tax-tolling payments in May 2016, subject to Rehabilitator review.
- Contractual obligations totaled $10.6 billion, including $8.5 billion of loss and loss expenses and $2.0 billion of surplus-note obligations. The timing of claims and surplus-note payments is uncertain and subject to regulatory or Rehabilitator approval.
Material changes versus the prior comparable period
- Net guaranteed par outstanding declined 25% to $108.3 billion from $144.7 billion. Below-investment-grade exposure declined 22% to $19.8 billion from $25.3 billion.
- Public finance exposure declined 30% to $65.4 billion; structured finance declined 17% to $21.8 billion; international finance declined 16% to $21.0 billion.
- Loss reserves improved due mainly to RMBS performance and higher representation-and-warranty recovery estimates, student-loan commutations and reduced Ambac UK claim expectations. These benefits were partly offset by $161.9 million of interest accrued on Deferred Amounts and deterioration in certain domestic public finance credits.
- Ambac acquired $635.2 million of distressed Ambac-insured securities, including $590.0 million of insured RMBS allocated to the Segregated Account.
- The Financial Services segment remained in runoff. Investment agreement obligations declined to $100.4 million from $160.1 million, while derivative liabilities declined to $353.4 million from $406.9 million.
- Accumulated other comprehensive income declined to $15.2 million from $220.3 million, primarily reflecting unrealized investment losses and foreign-currency translation losses.
- The company recorded a full $514.5 million goodwill impairment after an interim test concluded that the Financial Guarantee reporting unit had zero implied goodwill.
Guidance, outlook, risks and unusual items
- No conventional earnings or revenue guidance is provided. Management’s outlook centers on runoff, loss mitigation, recoveries, commutations, asset purchases and potential diversification.
- In January 2016, after year-end, Ambac Assurance settled RMBS litigation with JPMorgan for $995.0 million in cash. The settlement was incorporated into year-end reserve estimates because it provided evidence about conditions existing at December 31, 2015.
- Ambac’s $2.8 billion of estimated RMBS representation-and-warranty recoveries are highly uncertain. Management stated that failure to recover amounts other than the JPMorgan settlement could reduce stockholders’ equity from $1.958 billion to approximately $151 million.
- Puerto Rico is a significant stressed exposure: approximately $2.163 billion of net par, all internally rated below investment grade. Ambac challenged Puerto Rico’s revenue “clawback” and priority-debt actions in court.
- The Segregated Account generally pays 45% of permitted policy claims initially, with the remaining Deferred Amount accruing interest at an effective annual rate of 5.1%. Investors filed a February 2016 motion seeking a substantial increase in the interim payment percentage.
- Ambac Assurance cannot write new business and is highly unlikely to pay dividends to the holding company for the foreseeable future. Ambac UK is also in runoff and was deficient in applicable regulatory capital at December 31, 2015; discussions with UK regulators were ongoing.
- OCI has disapproved scheduled interest payments on Ambac Assurance and Segregated Account surplus notes from 2011 through 2015. Accrued interest on third-party surplus notes and junior surplus notes was $293.7 million and $57.1 million, respectively, at year-end.
- Other key risks include municipal defaults and bankruptcies, RMBS and private student-loan deterioration, inadequate reserves, model and valuation uncertainty, reinsurance counterparty risk, interest-rate and spread volatility, litigation, regulatory intervention, rehabilitation of Ambac Assurance, cyber risk and inability to monetize assets or execute liability-management transactions.
Important facts an investor should verify
- Confirm the issuer identity: the supplied filing is Ambac Financial Group, Inc.’s 2015 Form 10-K, not a filing for Octave Specialty Group Inc.
- Reconcile GAAP net income of $493.4 million with non-GAAP operating earnings of $1.165 billion and assess the effect of goodwill impairment, insurance-intangible amortization, VIE accounting and fair-value adjustments.
- Evaluate the collectability, timing and legal enforceability of the estimated $2.8 billion of RMBS recoveries, including the $995.0 million JPMorgan settlement.
- Assess whether loss reserves adequately reflect the stated stress sensitivities: approximately $111 million for RMBS, $331 million for student loans, $1.324 billion for public finance and $421 million for other credits.
- Review liquidity available at both the holding-company and Ambac Assurance levels, including collateral requirements, claim payments, surplus-note obligations and restricted dividend capacity.
- Monitor the Segregated Account rehabilitation proceedings, the Rehabilitator’s control over claims and recoveries, and the investors’ motion to increase interim payments.
- Review Puerto Rico litigation and exposure, Ambac UK’s regulatory-capital deficiency, and the risk of rehabilitation proceedings against Ambac Assurance.
- Consider the audit report’s substantial-doubt going-concern paragraph and management’s plans for maintaining liquidity and realizing value from Ambac Assurance.